keros strategic alternatives - SERP Analysis

https://ir.kerostx.com/news-releases/news-release-details/keros-therapeutics-announces-review-strategic-alternatives

https://ir.kerostx.com/news-releases/news-release-details/keros-announces-return-375-million-excess-capital-stockholders

https://www.globenewswire.com/news-release/2025/04/10/3059059/0/en/Keros-Therapeutics-Announces-Review-of-Strategic-Alternatives.html

https://ir.kerostx.com/news-releases/news-release-details/keros-reinforces-commitment-maximizing-stockholder-value

https://www.nasdaq.com/articles/keros-therapeutics-announces-375-million-capital-return-plan-following-strategic-review

https://www.tipranks.com/news/company-announcements/keros-therapeutics-concludes-strategic-alternatives-review

https://ir.kerostx.com/news-releases/news-release-details/keros-therapeutics-announces-tropos-topline-data-and-corporate

https://www.globenewswire.com/news-release/2025/06/09/3095712/0/en/Keros-Announces-Return-of-375-Million-in-Excess-Capital-to-Stockholders.html

https://ir.kerostx.com/news-releases/news-release-details/keros-therapeutics-highlights-commitment-maximizing-stockholder

https://finance.yahoo.com/news/kros-initiates-exploring-strategic-alternatives-155700972.html

https://www.stocktitan.net/news/KROS/keros-announces-return-of-375-million-in-excess-capital-to-v85e4mlof4wn.html

https://seekingalpha.com/article/4774568-keros-therapeutics-strategic-alternatives-could-bring-about-value-creation

https://finimize.com/content/keros-therapeutics-explores-major-strategic-alternatives-with-share-price-jump

https://www.reuters.com/sustainability/keros-therapeutics-adopts-poison-pill-plan-2025-04-10/

https://www.itiger.com/news/2534516043

https://www.marketscreener.com/quote/stock/KEROS-THERAPEUTICS-INC-106001599/news/Keros-Therapeutics-Concludes-Review-Process-to-Evaluate-Strategic-Alternatives-to-Maximize-Stockhold-50205864/

https://www.itiger.com/news/2536681383

https://www.ainvest.com/news/keros-therapeutics-crossroads-strategy-creation-biotech-2504/

https://ir.kerostx.com/news-events/press-releases

https://www.tradingview.com/news/reuters.com,2025:newsml_FWN3RP02K:0-keros-therapeutics-board-undertaking-formal-review-process-to-evaluate-strategic-alternatives/

https://www.benzinga.com/general/biotech/25/04/44746372/keros-therapeutics-goes-up-for-sale-on-heels-of-stockholder-rights-plan

https://www.streetinsider.com/Corporate%2BNews/Keros%2BTherapeutics%2B%28KROS%29%2BAnnounces%2BReview%2Bof%2BStrategic%2BAlternatives/24622889.html

https://www.tipranks.com/news/the-fly/keros-reviewing-strategic-alternatives-adopts-shareholder-rights-plan

https://www.stocktitan.net/news/KROS/keros-therapeutics-announces-review-of-strategic-dbcdldglv1cy.html

https://www.marketscreener.com/quote/stock/KEROS-THERAPEUTICS-INC-106001599/news/Keros-Therapeutics-Board-Initiates-Review-of-Strategic-Alternatives-49585183/

https://www.theglobeandmail.com/investing/markets/stocks/KROS-Q/pressreleases/32302394/keros-reinforces-commitment-to-maximizing-stockholder-value/

http://clarkstreetvalue.blogspot.com/2025/01/keros-therapeutics-pre-sa-broken.html

https://www.borsaitaliana.it/borsa/notizie/radiocor/finance/dettaglio/keros-therapeutics-considering-strategic-options-including-sale-nRC_10042025_1852_601146191.html?lang=en

https://www.ainvest.com/news/keros-therapeutics-stock-soars-19-55-strategic-review-2504/

https://ir.kerostx.com/news-releases/news-release-details/leading-independent-proxy-advisory-firm-glass-lewis-recommends

https://slashdot.org/software/p/Keros-Digital/alternatives

https://www.listingtrack.io/deal/14755

https://x.com/theflynews/status/1910294188412850673

https://www.fiercebiotech.com/biotech/keros-considers-sale-strengthens-defense-against-activist-investors

https://www.sec.gov/Archives/edgar/data/0001664710/000166471025000052/exhibit99152925pr.htm

https://www.medthority.com/news/2025/5/-topline-data-announced-from-the-tropos-trial-a-phase-ii-clinical-trial-of-cibotercept-ker-012-in-patients-with-pulmonary-arterial-hypertension.--keros-therapeutics

https://dcfmodeling.com/blogs/health/kros-financial-health

https://fintool.com/app/research/companies/KROS

https://finnhub.io/api/news?id=17f7fa329b98a046142277e6f2db248ffc714502c3e815b800a3546ebe3dffac

https://www.owler.com/company/kerostx

https://base.report/ticker/KROS

https://tiblio.com/research/tickers/KROS

https://www.waiker.ai/data-lab/waiker-news/3637

https://ebs.publicnow.com/view/D22D4FDCD4F9575787CAE7D2B723111F9F5E1D9B

https://www.stockinsights.ai/us/KROS/8-K/management-changes-20250609-b98

https://stockanalysis.com/stocks/kros/

https://www.sec.gov/Archives/edgar/data/1664710/000166471025000045/exhibit991q12025.htm

https://finviz.com/quote.ashx?t=KROS&b=2&p=d&ty=ocv&e=2025-06-20

https://finance.yahoo.com/quote/KROS?s=panabee

https://www.cbinsights.com/company/keros-therapeutics

https://www.etfchannel.com/symbol/kros/

https://www.wallstreetzen.com/how-to-buy-keros-therapeutics-stock

https://x.com/InsideArbitrage/status/1910590633711919123

https://www.fiercebiotech.com/biotech/keros-culls-pah-asset-prompting-layoffs-70-workers

https://www.youtube.com/watch?v=gsslQLdU7-s

https://www.linkedin.com/posts/keros-therapeutics_hiring-jobopening-careers-activity-7188159956351688704-I0aI

https://www.etoro.com/markets/kros

https://ir.kerostx.com/news-releases/news-release-details/keros-therapeutics-reports-recent-first-quarter-2025-financial

https://www.etfchannel.com/etfs/?a=detailed&ticker=KROS

https://finviz.com/quote.ashx?t=KROS&ty=oc

https://www.linkedin.com/jobs/view/senior-vice-president-corporate-strategy-at-keros-therapeutics-4088756240

https://mma.prnewswire.com/media/2685112/ADAR1_Presentation.pdf?p=pdf

https://cbs4indy.com/business/press-releases/globenewswire/9465142/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://www.kron4.com/business/press-releases/globenewswire/9465142/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://www.cbs42.com/business/press-releases/globenewswire/9465142/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://fox59.com/business/press-releases/globenewswire/9465142/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://www.wjbf.com/business/press-releases/globenewswire/9458646/leading-independent-proxy-advisory-firm-glass-lewis-recommends-stockholders-vote-for-all-of-keros-director-nominees/

https://www.turnerseedinc.com/markets/stocks.php?article=globenews-2025-6-9-keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://seekingalpha.com/symbol/KROS/analysis

https://www.nasdaq.com/press-release/keros-therapeutics-highlights-commitment-maximizing-stockholder-value-2025-05-19

https://www.quiverquant.com/news/Keros%2BTherapeutics%2BUrges%2BStockholders%2Bto%2BSupport%2BBoard%2BNominees%2BAmid%2BADAR1%2BCapital%2BManagement%27s%2BRecent%2BCommunications

https://ktla.com/business/press-releases/globenewswire/9465142/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://www.wate.com/business/press-releases/globenewswire/9465142/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://wgno.com/business/press-releases/globenewswire/9465142/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://biotech.caboodleai.net/article/203805/keros-considers-a-sale-strengthens-defense-against-potential-activist-investors

https://www.abc27.com/business/press-releases/globenewswire/9465142/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://www.theglobeandmail.com/investing/markets/stocks/KROS-Q/pressreleases/32781806/keros-announces-return-of-375-million-in-excess-capital-to-stockholders/

https://www.rttnews.com/3542860/keros-therapeutics-to-discontinue-cibotercept-development-cut-45-of-workforce-stock-down.aspx

https://www.citybiz.co/article/700098/keros-therapeutics-announces-corporate-restructuring/?abkw=citybizboston

https://www.wjhl.com/business/press-releases/globenewswire/9458646/leading-independent-proxy-advisory-firm-glass-lewis-recommends-stockholders-vote-for-all-of-keros-director-nominees

https://www.rochesterfirst.com/business/press-releases/globenewswire/9465142/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://www.marketwatch.com/story/keros-therapeutics-shareholder-adar1-capital-to-withhold-votes-for-two-board-members-510b5c01?mod=mw_quote_news

https://www.wowktv.com/business/press-releases/globenewswire/9465142/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://www.investing.com/news/stock-market-news/keros-therapeutics-stock-jumps-on-strategic-review-potential-sale-93CH-3979677

https://www.pharmaceutical-technology.com/news/keros-therapeutics-considers-sale-amid-investor-pressure/

https://www.counton2.com/business/press-releases/globenewswire/9458646/leading-independent-proxy-advisory-firm-glass-lewis-recommends-stockholders-vote-for-all-of-keros-director-nominees/

https://www.wbtw.com/business/press-releases/globenewswire/9465142/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://www.wkrg.com/business/press-releases/globenewswire/9465142/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://www.holdingschannel.com/quotes/?a=news&ticker=a&w=&story=202506PZONE99465142

https://www.cnn.com/markets/stocks/KROS

https://www.tradingview.com/news/reuters.com,2025-06-09:newsml_GNX2kKyLN:0-keros-announces-return-of-375-million-in-excess-capital-to-stockholders/

https://www.cnbc.com/quotes/KROS

https://www.barchart.com/story/news/32465537/keros-therapeutics-highlights-commitment-to-maximizing-stockholder-value

https://www.streetinsider.com/Corporate%2BNews/Keros%2BTherapeutics%2B%28KROS%29%2BReturn%2Bof%2B%24375M%2Bin%2BExcess%2BCapital%2Bto%2BStockholders/24911806.html

https://www.cbs42.com/business/press-releases/globenewswire/9458646/leading-independent-proxy-advisory-firm-glass-lewis-recommends-stockholders-vote-for-all-of-keros-director-nominees/

https://www.gurufocus.com/news/2914821/keros-announces-return-of-375-million-in-excess-capital-to-stockholders

https://ir.kerostx.com/static-files/d568b3cc-d94a-49c7-8e2e-107397caf0e5

https://www.yetanothervalueblog.com/p/an-open-letter-to-the-keros-board

https://www.tmcnet.com/usubmit/-keros-announces-return-375-million-excess-capital-stockholders-/2025/06/09/10206207.htm